Pediatric Mycoplasma Pneumoniae Pneumonia
Conditions
Interventions
Control Group :Before study initiation, pediatricians, primary nurses, and research assistants participating in the trial received standardized training. The training covered the inclusion and exclusi
(2) administration of anti-infective therapy, nebulization, oxygen therapy, and symptomatic treatment (antipyretics, antitussives, and expectorants) according to medical orders, with close monitoring
(3) providing guardians with information about the ward environment, hospital regulations, and basic safety precautions, and addressing questions regarding medication use, diagnostic procedures, and d
(4) delivering general health education once the child’s condition had stabilized, including appropriate medication use, maintenance of airway patency, rest, and dietary advice
(5) assisting with discharge procedures when discharge criteria were met, and verbally informing guardians of follow-up schedules and key precautions
(6) conducting post-discharge follow-up by telephone or outpatient visits according to routine departmental practice.
Intervention Group:Intervention group (usual care + IKAP intervention): Children in the intervention group received the same usual care as
Sponsors
Lanzhou Maternal and Child Health Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 13 Years
Inclusion criteria
Inclusion criteria: 1.Age between 0 and 14 years old; 2. Positive for Mycoplasma pneumoniae IgM antibody in the respiratory tract eight-panel test using the colloidal gold method, or MP antibody titer >= 1:40 in passive agglutination test; 3. No complications other than respiratory and digestive tracts (manifestations outside the respiratory and digestive systems); 4. The child and family members are informed of the condition and are willing to participate in the study at the time of the researcher's request.
Exclusion criteria
Exclusion criteria: Children meeting any of the following criteria will be excluded: 1. A history of severe neuropsychiatric disorders, such as mental illness or cognitive impairment; 2. The child or the primary caregiver has language or cognitive impairments that prevent effective communication, making it impossible to complete follow-up and questionnaire assessments; 3. Participation in other clinical studies or care interventions that may affect the outcome of hospitalization; 4. Transfer to another hospital, self-discharge, or other reasons that prevent the completion of the intervention or outcome assessment, resulting in a large amount of missing data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of hospital stay;Total medical expenses;Family satisfaction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Age;Gender;Admission Diagnosis;Number of Symptoms;Medical Insurance Pooling Expenses;Self-Paid Expenses;30-Day Readmission; | — |
Countries
China
Contacts
Public ContactZhang Yuexia
Lanzhou Maternal and Child Health Hospital
Outcome results
None listed